LYB
20
-9
O
57
2
EQT
65
8
ROP
50
5
PYPL
50
-4
IFF
60
-6
NSC
64
2
RRC
58
6
MCD
46
8
COF
65
2
L
69
-2
ROK
64
4
ALLE
46
-2
AXP
71
2
AAL
56
5
MA
48
2
YUM
52
2
TROW
58
5
SJM
14
-2
PNC
75
6
LYB
20
-9
O
57
2
EQT
65
8
ROP
50
5
PYPL
50
-4
IFF
60
-6
NSC
64
2
RRC
58
6
MCD
46
8
COF
65
2
L
69
-2
ROK
64
4
ALLE
46
-2
AXP
71
2
AAL
56
5
MA
48
2
YUM
52
2
TROW
58
5
SJM
14
-2
PNC
75
6
Financhill
Back

Chugai Pharmaceutical Co., Ltd. 10K Form

Buy
56

CHGCY
Chugai Pharmaceutical Co., Ltd.

Last Price:
$27.06
Seasonality Move:
2.76%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CHGCY News And Ratings

See the #1 stock for the next 7 days that we like better than CHGCY

CHGCY Financial Statistics

Sales & Book Value

Annual Sales: $7.7B
Cash Flow: $422.1M
Price / Cash Flow: 38
Annual Sales: $3.89
Price / Book: 6.79

Profitability

EPS (TTM): 0.80980
Net Income (TTM): $2.7B
Gross Margin: $5.5B
Return on Equity: 20.83%
Return on Assets: 18.16%

Chugai Pharmaceutical Co., Ltd. Earnings Forecast

Key Chugai Pharmaceutical Co., Ltd. Financial Ratios

  • The Gross Profit Margin over the past 34 years for CHGCY is 70.97%.
  • The Selling, General & Administrative Expenses for CHGCY have been equal to 9.41% of Gross Profit Margin.
  • The Research & Development expenses have been 15.10% of Revenue.
  • The Interest Expense is 0.02% of Operating Income.
  • The Net Earning history of CHGCY is 33.09% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 21 years.

Chugai Pharmaceutical Co., Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CHGCY
Website: chugai-pharm.co.jp

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 5.68
Quick Ratio: 4.62

Price-to-Earnings

Trailing P/E Ratio: 33.99
Forward P/E Ratio: 0

CHGCY Technical Analysis vs Fundamental Analysis

Buy
56
Chugai Pharmaceutical Co., Ltd. (CHGCY) is a Buy

Is Chugai Pharmaceutical Co., Ltd. a Buy or a Sell?